Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings
- PMID: 20720033
- PMCID: PMC2953088
- DOI: 10.1128/JCM.01053-10
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings
Abstract
The recently introduced Xpert MTB/RIF assay (Xpert) has point-of-care potential, but its capacity for biohazard containment remained to be studied. We compared the bioaerosols generated by the Xpert assay to acid-fast bacillus (AFB) microscope slide smear preparation. The Xpert assay sample treatment reagent (SR) was also studied for its sterilizing capacity, stability, and effect on assay sensitivity after prolonged treatment. During the preparation of AFB smears, sputum samples spiked with Mycobacterium bovis BCG at 5 × 10(8) CFU/ml produced 16 and 325 CFU/m(3) air measured with an Andersen impactor or BioSampler, respectively. In contrast, neither the sample preparation steps for the Xpert assay nor its automated processing produced any culturable bioaerosols. In testing of SR sterilizing capacity, clinical sputum samples from strongly smear-positive tuberculosis patients treated with SR at a 2:1 ratio eliminated Mycobacterium tuberculosis growth in all but 1/39 or 3/45 samples cultured on solid or liquid medium, respectively. These few unsterilized samples had a mean 13.1-day delay in the time to positive culture. SR treatment at a 3:1 ratio eliminated growth in all samples. SR retained a greater than 6-log-unit killing capacity despite storage at temperatures spanning 4 to 45°C for at least 3 months. The effect of prolonged SR sample treatment was also studied. Spiked sputum samples could be incubated in SR for up to 3 days without affecting Xpert sensitivity for M. tuberculosis detection and up to 8 h without affecting specificity for rifampin resistance detection. These results suggest that benchtop use of the Xpert MTB/RIF assay limits infection risk to the user.
Figures




Similar articles
-
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17. mBio. 2017. PMID: 28851844 Free PMC article.
-
Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.J Clin Microbiol. 2014 Jun;52(6):1846-52. doi: 10.1128/JCM.03005-13. Epub 2014 Mar 19. J Clin Microbiol. 2014. PMID: 24648554 Free PMC article.
-
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.J Clin Microbiol. 2010 Jan;48(1):229-37. doi: 10.1128/JCM.01463-09. Epub 2009 Oct 28. J Clin Microbiol. 2010. PMID: 19864480 Free PMC article.
-
Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.BMC Microbiol. 2015 Sep 29;15:191. doi: 10.1186/s12866-015-0528-z. BMC Microbiol. 2015. PMID: 26420261 Free PMC article.
-
Rapid diagnosis of extrapulmonary tuberculosis with Xpert Mycobacterium tuberculosis/rifampicin assay.J Med Microbiol. 2017 Jul;66(7):910-914. doi: 10.1099/jmm.0.000522. Epub 2017 Jul 15. J Med Microbiol. 2017. PMID: 28708053
Cited by
-
Analysis of unsuccessful tests and the effect of prolonged clinical sample preprocessing in the GeneXpert MTB/RIF assay.BMC Infect Dis. 2024 Aug 1;24(1):770. doi: 10.1186/s12879-024-09684-4. BMC Infect Dis. 2024. PMID: 39090540 Free PMC article.
-
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.AIDS. 2012 May 15;26(8):987-95. doi: 10.1097/QAD.0b013e3283522d47. AIDS. 2012. PMID: 22333751 Free PMC article.
-
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18. Lancet. 2011. PMID: 21507477 Free PMC article.
-
Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.Expert Rev Mol Diagn. 2016;16(3):323-41. doi: 10.1586/14737159.2016.1134325. Epub 2016 Jan 11. Expert Rev Mol Diagn. 2016. PMID: 26689497 Free PMC article. Review.
-
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593. doi: 10.1002/14651858.CD009593.pub4. PMID: 24448973 Free PMC article. Updated.
References
-
- Ad Hoc Committee for the Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings. 1996. Guidelines for preventing the transmission of tuberculosis in Canadian health care facilities and other institutional settings. Can. Commun. Dis. Rep. 22(Suppl. 1):i-iv, 1-55. - PubMed
-
- An, H. R., G. Mainelis, and M. Yao. 2004. Evaluation of a high-volume portable bioaerosol sampler in laboratory and field environments. Indoor Air 14:385-393. - PubMed
-
- Association for the Advancement of Medical Instrumentation. 2003. Sterilization of health care products—requirements for products labeled “sterile.” Standard ANSI/AAMI ST67. Association for the Advancement of Medical Instrumentation, Arlington, VA.
-
- Bonnet, M., A. Ramsay, W. Githui, L. Gagnidze, F. Varaine, and P. J. Guerin. 2008. Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV. Clin. Infect. Dis. 46:1710-1716. - PubMed
-
- Caulfield, J. L., J. S. Wishnok, and S. R. Tannenbaum. 1998. Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J. Biol. Chem. 273:12689-12695. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials